Clin2
NCT07842705Possibly a fitNot yet recruiting

Heart changes in children with Guillain-Barré syndrome

Myocardial DysfunctionGuillain-Barre Syndrome

Part of Brain & nervous system, Immune system & allergy clinical trials.

This study looks at how Guillain-Barré syndrome, a condition that causes muscle weakness, might affect the heart in children. It aims to find out if there are heart problems that need extra care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
72 people
Ages
1 month to 18 years
Study type
Observational

Who can take part

  • Your child is between 1 month and 18 years old.
  • Your child has been diagnosed with Guillain-Barré syndrome.
  • Neurological symptoms started within 2 weeks before coming to the hospital.
  • Your child does not have any pre-existing heart disease.
  • You are willing to give written consent for your child to participate.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06940908Recruiting
Living with Guillain-Barré syndrome as a child

This study interviews children who had Guillain-Barré syndrome (GBS) to understand their experiences after recovery. It may help doctors better support young patients with GBS.

Montpellier, Occitanie
NCT07866898Not yet recruiting
Ultrasound of arm and leg nerves in children with Guillain-Barré syndrome

This study uses ultrasound to look at the nerves in children with Guillain-Barré syndrome, a condition that causes weakness. It aims to see if ultrasound can help doctors understand or monitor the disease.

NCT05461898Recruiting
Rehabilitation program for adults with Guillain-Barré syndrome

This trial studies whether an inpatient rehabilitation program can help people with Guillain-Barré syndrome. It may be useful if you need structured therapy and support during recovery.

Vila Nova de Gaia
NCT05114941Not yet recruiting
Comparing two blood treatments for Guillain-Barré syndrome

This trial compares two blood-based treatments for Guillain-Barré syndrome: one that filters antibodies from the blood (immunoadsorption) and one that uses donated antibodies (IVIG). Both aim to reduce nerve damage and speed up recovery, and researchers want to see which works better.

Zhengzhou, Henan
NCT07806916Not yet recruiting· Phase 2
Efgartigimod for recent Guillain-Barré syndrome

This trial tests whether an experimental drug called efgartigimod (given as an infusion) can help people with Guillain-Barré syndrome recover faster. It is for adults who recently developed symptoms and have significant weakness that affects their walking.

NCT06996509Recruiting
Noninvasive breathing support for Guillain-Barré syndrome

This trial tests whether noninvasive breathing support (like a mask or nasal prongs) can help people with Guillain-Barré syndrome who have trouble breathing. It aims to see if this approach can avoid the need for a breathing tube.

Asyut, Assuit

Hear when a new Guillain Barré Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.